When available, the educational toolkit will provide patients with sickle cell disease information on the gene therapy process, what to expect from therapy, and the importance of follow-up care.

The sale of bluebird bio and Pfizer’s decision to drop a gene therapy for hemophilia have led to some anxiety regarding the future of cell and gene therapy (CGT). As the chief executive officer ...

used for gene therapy or as a vaccine [Thomas Leach/Science Photo Library/Getty Images] A new generation of automated technologies in cell and gene therapy manufacturing systems will help more ...

Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient’s own immune cells to fight disease, including genetic engineering of immune cells to attack ...

Researchers have identified an early postnatal window that allows gene transfer to circulating blood stem cells, advancing ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

They’re rare inside tumors but when present can trigger powerful immune responses that eat away at the cancer’s protective shield and recruit T cells to the target. Mice treated with the gene therapy ...

Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct. 21. Kendric Cromer began treatment with Bluebird bio ...